Dynavax Technologies | DVAX - Market Capitalization



Dynavax Technologies reported $1.31B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
Adma Biologics USD 4.08B 267M Sep/2025
Amgen USD 150.13B 17.37B Jun/2025
AstraZeneca GBP 215.51B 41B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
BioMarin Pharmaceutical USD 10.54B 3.01B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Dynavax Technologies USD 1.19B 421M Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
Glaxosmithkline USD 82.21B 2.63B Sep/2025
Merck USD 198.77B 27.1B Jun/2025
Neurocrine Biosciences USD 12.44B 1.5B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Sarepta Therapeutics USD 1.68B 4.51B Jun/2025
TG Therapeutics USD 5.71B 526M Jun/2025
Vertex Pharmaceuticals USD 114.33B 10.31B Jun/2025